Omniox
Latest round
- Series D
Last raised
- Mar 2018
Total raised
- $87M
Investors
- 7
About Omniox
Omniox, Inc.Founded in 2006 and headquartered in San Carlos, US, Omniox, Inc. focuses on developing advanced therapies using its proprietary H-NOX platform.Omniox specializes in the development of innovative biotherapeutics through its proprietary H-NOX platform technology, which creates advanced oxygen delivery vehicles known as OMX biologics. These products are engineered to safely deliver oxygen to hypoxic tissues, aiming to restore normal tissue function and improve clinical outcomes. The primary end users are healthcare providers and patients suffering from conditions like cancer and other chronic diseases.Omniox's revenue model is structured around B2B transactions, primarily engaging in partnerships with healthcare institutions and pharmaceutical companies. The company licenses OMX biologics for clinical use or participates in joint development programs, often involving milestone payments and royalties based on product sales. The company is also targeting expansion into additional European markets by 2025 to broaden its reach and address new patient populations.
Who invested in Omniox
7 investors across 4 rounds
See all investors in Omniox
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Omniox
Who invested in Omniox?
Omniox has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Omniox raised?
Omniox has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Omniox last raise money?
Omniox's most recent round on record is a Series D, in Mar 2018.
What does Omniox do?
Omniox is a pharmaceuticals company.
Where is Omniox headquartered?
Omniox is headquartered in San Carlos, US.
Which VCs invest in companies like Omniox?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Omniox's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Omniox? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.